Last reviewed · How we verify

NCT03529240

Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption

Completed NA Last updated 18 May 2018
What this trial tests

NA trial testing Kinesiology Taping in Performance in 45 participants. Completed in 5 October 2017.

Timeline
10 June 2017
Primary endpoint
5 August 2017
5 October 2017

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment45
Start date10 June 2017
Primary completion5 August 2017
Estimated completion5 October 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 5 to 14, male only, with Performance or Energy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators investigated that the effects of kinesilogy taping on performance, energy consumption and gait characteristics in patients with Duchenne Muscular Dystrophy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kinesiology Taping

Trials testing the same drug.

Other recruiting trials for Performance

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing